Japan’s largest drugmaker Takeda has announced new data from VERDICT showing that treating adults with intravenous Entyvio ...

South Korea’s Samsung Bioepis announced a landmark 10-year agreement with its local partners in Brazil - state-level public ...

Australian biotech Starpharma saw its shares tumble 33% to A$0.50 today, after announcing that it has increased its equity ...

US biotech company TriGemX Bio has agreed to go public through a merger expected to generate about $246 million in gross ...

The US Food and Drug Administration has granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab ...

German biotech Repairon, which is developing regenerative cardiac therapies, today announced the appointment of Detlef ...

US drugmaker Collegium Pharmaceuticals announced a settlement agreement between the company and Germany’s Grunenthal.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Redemplo (plozasiran) to reduce ...

US biotech major Amgen and the UK’s AstraZeneca today announced full results from the Phase III CROSSING trial of Tezspire ...

US pharma major Eli Lilly (NYSE: LLY) has partnered with Chinese biotech company METiS TechBio (HKEX: 7666) to develop lipid nanoparticles (LNPs) that could deliver medicines more precisely to ...

Germany’s Merck KGaA today announced its entry into a definitive agreement to acquire Silence Therapeutics, sending the ...

Danish clinical-stage techbio company Evaxion, which is developing novel immunotherapies with its pioneering AI-Immunology platform, announced new three-year clinical outcome data for personalized ...